157 related articles for article (PubMed ID: 38637834)
21. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
Kyriazoglou A; Liontos M; Ziogas DC; Zagouri F; Koutsoukos K; Tsironis G; Tsiara A; Kaparelou M; Zakopoulou R; Thomakos N; Haidopoulos D; Papaspyrou I; Rodolakis A; Bamias A; Dimopoulos MA
BMC Cancer; 2018 Dec; 18(1):1247. PubMed ID: 30541504
[TBL] [Abstract][Full Text] [Related]
22. Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II.
Raney RB; Gehan EA; Hays DM; Tefft M; Newton WA; Haeberlen V; Maurer HM
Cancer; 1990 Nov; 66(10):2072-81. PubMed ID: 2224761
[TBL] [Abstract][Full Text] [Related]
23. Current concepts in the imaging of uterine sarcoma.
Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
[TBL] [Abstract][Full Text] [Related]
24. Uterine sarcomas.
Punnonen R; Lauslahti K; Pystynen P; Kauppila O
Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
[TBL] [Abstract][Full Text] [Related]
25. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
26. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound Features of Uterine Sarcomas.
Oh J; Park SB; Park HJ; Lee ES
Ultrasound Q; 2019 Dec; 35(4):376-384. PubMed ID: 31094892
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.
Makker V; Kravetz SJ; Gallagher J; Orodel OP; Zhou Q; Iasonos A; DeLair D; Aghajanian C; Hensley ML
Int J Gynecol Cancer; 2013 Nov; 23(9):1635-41. PubMed ID: 24172099
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
30. A case of three rare uterine neoplasms in the same surgical specimen.
Giuliani A; Romano L; Romanzi F; Giubbolini G; Coletti G; Di Stefano N; Le'Clerc JN; Schietroma M; Carlei F; Di Stefano L
Ann Ital Chir; 2020 Jan; 9():. PubMed ID: 32129176
[TBL] [Abstract][Full Text] [Related]
31. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Brooks SE; Zhan M; Cote T; Baquet CR
Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Zapardiel I; Gracia Segovia M; Macuks R; Mancari R; Achimas-Cadariu P; Corrado G; Bartusevicius A; Sukhin V; Muruzabal JC; Coronado Martín PJ; Gardella B; Piek JM; Concin N; Arab C; Papatheodorou D; Polterauer S; Iacoponi S; Nieto T; Lopez-Sanclemente MC; Trukhan H; Gil MM; Bakinovskaya I; Dalamanava A; Cucurull M; Rovski D; Baquedano L; Chiva L; Mardas M; Mavrichev SA; Klat J; Lopez de la Manzanara CA; Yildirim Y;
Int J Gynecol Cancer; 2023 Jun; 33(6):897-904. PubMed ID: 37192761
[TBL] [Abstract][Full Text] [Related]
33. Uterine Sarcomas: Experience from a Tertiary Cancer Care Center from India.
Nusrath S; Bafna S; Rajagopalan R; Thammineedi SR; Raju KVVN; Patnaik SC; Pawar S; Reddy Y; Chavali RN; Murthy SS
Indian J Surg Oncol; 2019 Jun; 10(2):342-349. PubMed ID: 31168260
[TBL] [Abstract][Full Text] [Related]
34. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL
Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499
[TBL] [Abstract][Full Text] [Related]
35. [Uterine sarcomas: clinical and therapeutic aspects (10 cases)].
Hassini A; Khemiri B; Sfar E; Chelly D; Chennoufi MB; Chelly H
J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):348-55. PubMed ID: 16940904
[TBL] [Abstract][Full Text] [Related]
36. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
38. Rhabdomyosarcoma of the uterus: report of two cases, including one of the spindle cell variant.
McCluggage WG; Lioe TF; McClelland HR; Lamki H
Int J Gynecol Cancer; 2002; 12(1):128-32. PubMed ID: 11860548
[TBL] [Abstract][Full Text] [Related]
39. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
40. Sarcomas and carcinosarcomas of the uterine cervix.
Abell MR; Ramirez JA
Cancer; 1973 May; 31(5):1176-92. PubMed ID: 4705156
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
